Reaction equation
[F:1][C:2]1[CH:9]=[CH:8][CH:7]=[C:6]([F:10])[C:3]=1[CH:4]=O.[NH2:11][C:12]1[CH:13]=[C:14]2[C:18]3=[C:19]([CH2:21][O:22][CH2:23][CH2:24][N:17]3[C@H:16]3[CH2:25][CH2:26][N:27](C(OC(C)(C)C)=O)[CH2:28][C@@H:15]23)[CH:20]=1>>[F:1][C:2]1[CH:9]=[CH:8][CH:7]=[C:6]([F:10])[C:3]=1[CH2:4][NH:11][C:12]1[CH:13]=[C:14]2[C:18]3=[C:19]([CH2:21][O:22][CH2:23][CH2:24][N:17]3[C@H:16]3[CH2:25][CH2:26][NH:27][CH2:28][C@@H:15]23)[CH:20]=1Participants
3
Reactant 2
Product 1
Procedure
Using 2,6-difluorobenzaldehyde and following the procedures described in EXAMPLE 126, tert-butyl (7bR,11aS)-6-amino-1,2,7b,10,11,11a-hexahydro-4H-[1,4]oxazepino[6,5,4-hi]pyrido[4,3-b]indole-9(8H)-carboxylate from EXAMPLE 56, Part B was converted into the title compound of EXAMPLE 140. 1H NMR (CDCl3) δ: 7.25-7.15 (m, 2H), 6.90-6.82 (m, 2H), 6.50 (d, 1H, J=2.2 Hz), 6.30 (d, 1H, J=2.2 Hz), 4.58 (ABq, 2H, JAB=14.0 Hz), 4.35 (s, 2H), 4.20-4.13 (m, 1H), 3.72 (dd, 1H, J=11.5, 10.8 Hz), 3.33-3.25 (m, 1H), 3.22-3.08 (m, 2H), 3.02 (dd, 1H, J=12.4, 6.6 Hz), 2.95-2.85 (m, 2H), 2.65-2.57 (m, 1H), 2.44 (dd, 1H, J=12.3, 10.4 Hz), 1.95-1.80 (m, 2H). LRMS (ES)+: 372.4 (M+H)+.
Sources & evidence
- ORD record
- ord-c73a7e2701dc46c7b0e82f789a522cde
- Source dataset
- uspto-grants-2005_02
- Patent number
- US06849619B2
Linked notes
Loading…